JEFFREY E GERSHENWALD to Imidazoles
This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about Imidazoles.
Connection Strength
0.104
-
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
Score: 0.104